A Research Study to Show Aprocitentan is Efficacious and Safe to Treat Patients With Uncontrolled Blood Pressure and Chronic Kidney Disease.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The purpose of this research study is to show the blood pressure lowering effect of aprocitentan, a new drug, when added to the background antihypertensive therapy in patients with uncontrolled blood pressure and chronic kidney disease (CKD) stage 3 or 4. Participation in the research study will last up to 21 weeks (about 5 months).
Epistemonikos ID: a14551bf8dd9780695d66ac4b3eed6208273a736
First added on: May 06, 2024